PROJECT HEMOREGEN-721 | UNIVERSAL BLOOD FAILURE ATLAS

Comprehensive Taxonomy of Blood System Dysfunction, Communication Collapse, Regenerative Failure, Hemostatic Instability, and Blood Restoration Engineering

Program Code: HEMOREGEN-BLD-004

Division: HEMOREGEN-BLD-300

Parent Program: HEMOREGEN-BLD-000

Classification: Blood Systems Pathology and Restoration Atlas

Status: Master Reference Atlas v1.0

⸻

EXECUTIVE SUMMARY

The Universal Blood Failure Atlas establishes the first integrated SCF framework for classifying all blood-system dysfunction according to cellular, communicational, regenerative, metabolic, immune, and hemostatic failures.

Within PROJECT HEMOREGEN-721, blood failure is defined as the loss of functional integrity within one or more layers of the Blood Intelligence Network.

The atlas provides:

Universal blood failure taxonomy
Multi-layer fault architecture
Disease-state mapping
Communication failure analysis
Regenerative collapse modeling
Blood restoration engineering targets

This atlas serves as the pathology layer of the SCF Universal Blood Engineering Program.

⸻

SECTION I — SCF BLOOD FAILURE HYPOTHESIS

Core Principle

Healthy blood requires simultaneous integrity of:

Layer A

Cellular Integrity

⸻

Layer B

Communication Integrity

⸻

Layer C

Hemostatic Integrity

⸻

Layer D

Immune Integrity

⸻

Layer E

Regenerative Integrity

⸻

Layer F

Metabolic Integrity

⸻

Layer G

Organ Integration Integrity

⸻

Failure of one or more layers produces measurable blood dysfunction.

⸻

SECTION II — MASTER FAILURE TAXONOMY

BF-1

Cellular Failure

Definition:

Loss of blood-cell functionality.

⸻

BF-2

Communication Failure

Definition:

Loss of biological information transfer.

⸻

BF-3

Hemostatic Failure

Definition:

Failure of vascular protection and clot control.

⸻

BF-4

Immune Failure

Definition:

Failure of immune surveillance and coordination.

⸻

BF-5

Regenerative Failure

Definition:

Failure of hematopoietic renewal.

⸻

BF-6

Metabolic Failure

Definition:

Failure of transport and metabolic regulation.

⸻

BF-7

Connectome Failure

Definition:

Failure of blood-organ communication.

⸻

BF-8

Global Blood System Failure

Definition:

Simultaneous multi-layer collapse.

⸻

SECTION III — CELLULAR FAILURE ATLAS

BF-1A

Erythrocyte Failure

Affected Functions:

Oxygen transport
Carbon dioxide transport
Microvascular regulation

⸻

Failure Outcomes

Tissue hypoxia
Organ dysfunction
Metabolic stress

⸻

BF-1B

Platelet Failure

Affected Functions:

Clot formation
Vascular repair

⸻

Failure Outcomes

Hemorrhage
Delayed repair
Vascular instability

⸻

BF-1C

Neutrophil Failure

Affected Functions:

Rapid pathogen defense

⸻

Failure Outcomes

Infection susceptibility

⸻

BF-1D

Monocyte/Macrophage Failure

Affected Functions:

Surveillance
Debris clearance
Repair coordination

⸻

Failure Outcomes

Chronic inflammation
Impaired repair

⸻

BF-1E

Lymphocyte Failure

Affected Functions:

Adaptive immunity
Immune memory

⸻

Failure Outcomes

Immunodeficiency
Poor vaccine responsiveness

⸻

SECTION IV — BLOOD EV FAILURE ATLAS

BF-2A

EV Production Failure

Definition:

Insufficient EV generation.

⸻

Consequences

Communication loss
Delayed adaptation

⸻

BF-2B

Cargo Corruption

Definition:

Abnormal information packaging.

⸻

Consequences

Miscommunication
Pathological signaling

⸻

BF-2C

Address-Code Failure

Definition:

Loss of targeting specificity.

⸻

Consequences

Misrouting
Reduced therapeutic accuracy

⸻

BF-2D

EV Delivery Failure

Definition:

Failure of uptake and transfer.

⸻

Consequences

Communication interruption

⸻

BF-2E

Network Fragmentation

Definition:

Collapse of EV communication networks.

⸻

Consequences

Multi-organ desynchronization

⸻

SECTION V — HEMOSTATIC FAILURE ATLAS

BF-3A

Hypocoagulation Failure

Characteristics:

Reduced clot formation

⸻

Outcomes

Bleeding
Hemorrhage

⸻

BF-3B

Hypercoagulation Failure

Characteristics:

Excess clot formation

⸻

Outcomes

Thrombosis
Embolism

⸻

BF-3C

Platelet Communication Failure

Characteristics:

Defective injury signaling

⸻

Outcomes

Impaired repair

⸻

BF-3D

Endothelial Coordination Failure

Characteristics:

Vascular communication loss

⸻

Outcomes

Barrier dysfunction

⸻

SECTION VI — IMMUNE FAILURE ATLAS

BF-4A

APC Failure

Associated Program:

HEMOREGEN-IMM-001

⸻

Outcomes

Poor antigen presentation
Weak immune activation

⸻

BF-4B

Tolerance Failure

Associated Program:

HEMOREGEN-IMM-002

⸻

Outcomes

Autoimmunity
Chronic inflammation

⸻

BF-4C

Cytotoxic Failure

Associated Program:

HEMOREGEN-IMM-003

⸻

Outcomes

Tumor escape
Persistent infection

⸻

BF-4D

Immune Exhaustion Failure

Associated Program:

HEMOREGEN-IMM-005

⸻

Outcomes

Chronic immune dysfunction

⸻

SECTION VII — REGENERATIVE FAILURE ATLAS

BF-5A

HSC Failure

Characteristics:

Reduced self-renewal
Reduced differentiation

⸻

Outcomes

Bone marrow insufficiency

⸻

BF-5B

Niche Failure

Characteristics:

Microenvironment dysfunction

⸻

Outcomes

Stem-cell instability

⸻

BF-5C

Repair Communication Failure

Characteristics:

Impaired regenerative signaling

⸻

Outcomes

Delayed healing

⸻

BF-5D

Regenerative Exhaustion

Characteristics:

Long-term regenerative decline

⸻

Outcomes

Aging-related dysfunction

⸻

SECTION VIII — METABOLIC FAILURE ATLAS

BF-6A

Oxygen Transport Failure

Characteristics:

Reduced oxygen delivery

⸻

Outcomes

Systemic hypoxia

⸻

BF-6B

Iron Homeostasis Failure

Characteristics:

Iron imbalance

⸻

Outcomes

Ineffective hematopoiesis

⸻

BF-6C

Redox Failure

Characteristics:

Oxidative imbalance

⸻

Outcomes

Cellular injury

⸻

BF-6D

Energy-State Communication Failure

Characteristics:

Metabolic misreporting

⸻

Outcomes

Organ maladaptation

⸻

SECTION IX — BLOOD CONNECTOME FAILURE ATLAS

BF-7A

Brain-Blood Axis Failure

Outcomes:

Neuroimmune dysregulation

⸻

BF-7B

Gut-Blood Axis Failure

Outcomes:

Chronic inflammation
Barrier dysfunction

⸻

BF-7C

Liver-Blood Axis Failure

Outcomes:

Metabolic instability

⸻

BF-7D

Bone Marrow-Blood Axis Failure

Outcomes:

Regenerative collapse

⸻

BF-7E

Whole-Body Communication Failure

Outcomes:

Multi-organ dysfunction

⸻

SECTION X — DISEASE MAPPING MATRIX

Disease Class	Dominant Failure Types
Hemorrhagic Disorders	BF-3
Thrombotic Disorders	BF-3
Autoimmune Disorders	BF-2, BF-4
Immunodeficiency	BF-4
Leukemia	BF-1, BF-5
Bone Marrow Failure Syndromes	BF-5
Chronic Inflammatory Disorders	BF-2, BF-4, BF-7
Fibrotic Disorders	BF-2, BF-5, BF-7
Aging-Associated Dysfunction	BF-2, BF-5, BF-6
Multi-Organ Failure	BF-7, BF-8

⸻

SECTION XI — BLOOD FAILURE STAGING SYSTEM

Stage I

Compensated Dysfunction

Characteristics:

Early abnormalities
Functional reserve maintained

⸻

Stage II

Communication Drift

Characteristics:

Reduced efficiency
Early network instability

⸻

Stage III

Functional Failure

Characteristics:

Clinical manifestations emerge

⸻

Stage IV

Network Collapse

Characteristics:

Multi-system involvement

⸻

Stage V

Global Blood System Failure

Characteristics:

Life-threatening dysfunction

⸻

SECTION XII — UNIVERSAL BLOOD FAILURE INDEX (UBFI)

Domain	Score
Cellular Integrity	0–20
EV Communication Integrity	0–20
Hemostatic Integrity	0–20
Immune Integrity	0–20
Regenerative Integrity	0–20

Total:

0–100

⸻

Score	Interpretation
80–100	Healthy blood ecosystem
60–79	Blood-system stress
40–59	Progressive dysfunction
20–39	Severe blood failure
<20	Global blood-system collapse

⸻

SECTION XIII — BLOOD RESTORATION ENGINEERING FRAMEWORK

Restoration Class A

Cellular Reconstruction

Objectives:

Restore blood-cell populations

⸻

Restoration Class B

EV Communication Restoration

Objectives:

Rebuild communication networks

⸻

Restoration Class C

Hemostatic Rebalancing

Objectives:

Normalize clotting systems

⸻

Restoration Class D

Immune Recalibration

Objectives:

Restore surveillance and tolerance

⸻

Restoration Class E

Regenerative Reconstitution

Objectives:

Restore hematopoietic capacity

⸻

Restoration Class F

Connectome Reintegration

Objectives:

Restore organ-blood communication

⸻

SECTION XIV — HEMOREGEN BLOOD RESTORATION BLUEPRINT

HEM-BLD-RX-006

Blood Failure Diagnostics Platform

⸻

HEM-BLD-RX-007

Communication Restoration Platform

⸻

HEM-BLD-RX-008

Regenerative Hematology Platform

⸻

HEM-BLD-RX-009

Universal Blood Reconstruction Platform

⸻

HEM-BLD-RX-010

Blood Connectome Restoration Platform

⸻

TRANSLATIONAL DEVELOPMENT ROADMAP

BLD-F-H1

Failure Taxonomy Validation

BLD-F-H2

Multi-Omic Failure Mapping

BLD-F-H3

Communication Failure Modeling

BLD-F-H4

Restoration Target Discovery

BLD-F-H5

Clinical Translation

⸻

NEXT DELIVERABLE

HEMOREGEN-BLD-005 — Universal Hematopoietic Regeneration Atlas

Will establish:

Complete hematopoietic stem-cell architecture
Bone marrow regenerative ecosystems
Hematopoietic communication networks
Blood regeneration programs
Stem-cell engineering systems
Universal blood reconstruction framework

⸻

MASTER REGISTRY INDEX

HEMOREGEN-BLD-004 — Universal Blood Failure Atlas

HEM-BLD-RX-006 — Blood Failure Diagnostics Platform

HEM-BLD-RX-007 — Communication Restoration Platform

HEM-BLD-RX-008 — Regenerative Hematology Platform

HEM-BLD-RX-009 — Universal Blood Reconstruction Platform

HEM-BLD-RX-010 — Blood Connectome Restoration Platform

HEMOREGEN-BLD-000 — SCF Universal Blood Engineering Program

SCF-BLD-FAIL-0001 — Universal Blood Failure Systems Atlas

SCF-BLD-RESTORE-0001 — Blood Restoration Engineering Framework

SCF-BLD-PATHO-0001 — Blood Systems Pathophysiology Architecture

HEMOREGEN-721-PROG-0001 — Project HEMOREGEN-721 Master Program